{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:08:31Z","timestamp":1793214511675,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.msard.2020.102152","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T20:04:11Z","timestamp":1588536251000},"page":"102152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4524-9566","authenticated-orcid":false,"given":"Giuseppe","family":"Lopalco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sante","family":"Schiraldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Venerito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Guerriero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florenzo","family":"Iannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2020.102152_bib0001","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nm1585","article-title":"TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27\/ STAT1","volume":"13","author":"Amadi-Obi","year":"2007","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.msard.2020.102152_bib0002","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3899\/jrheum.160064","article-title":"Canakinumab for childhood sight-threatening refractory uveitis: a case series","volume":"43","author":"Brambilla","year":"2016","journal-title":"J. Rheumatol"},{"issue":"1","key":"10.1016\/j.msard.2020.102152_bib0003","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10067-014-2721-0","article-title":"The labyrinth of autoinflammatory disorders: a snapshot on the activity of a third-level center in Italy","volume":"34","author":"Cantarini","year":"2015","journal-title":"Clin. Rheumatol"},{"issue":"11","key":"10.1016\/j.msard.2020.102152_bib0004","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1136\/bjo.2005.075689","article-title":"Successful treatment of Wegener's granulomatosis associated scleritis with rituximab","volume":"89","author":"Cheung","year":"2005","journal-title":"The Brit. J. Ophthalmol."},{"issue":"9313","key":"10.1016\/j.msard.2020.102152_bib0005","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(02)08220-X","article-title":"Multiple sclerosis","volume":"359","author":"Compston","year":"2002","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.msard.2020.102152_bib0006","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s10067-015-3004-0","article-title":"Efficacy and safety profile of anti-interleukin-1 treatment in Beh\u00e7et's disease: a multicenter retrospective study","volume":"35","author":"Emmi","year":"2016","journal-title":"Clin. Rheumatol"},{"issue":"1","key":"10.1016\/j.msard.2020.102152_bib0007","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s10067-016-3506-4","article-title":"Interleukin (IL)-1 inhibition with anakinra and canakinumab in Beh\u00e7et's disease-related uveitis: a multicenter retrospective observational study","volume":"36","author":"Fabiani","year":"2017","journal-title":"Clin. Rheumatol"},{"issue":"2","key":"10.1016\/j.msard.2020.102152_bib0008","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s10067-018-4228-6","article-title":"Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients","volume":"38","author":"Fabiani","year":"2019","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.msard.2020.102152_bib0009","first-page":"1","article-title":"The presence of uveitis Is is associated with a sustained response to the interleukin (IL)-1 inhibitors anakinra and canakinumab in Beh\u00e7et's disease","author":"Fabiani","year":"2018","journal-title":"Ocul. Immunol. Inflamm"},{"issue":"7","key":"10.1016\/j.msard.2020.102152_bib0010","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing\u2013remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N. Engl. J. Med"},{"issue":"9","key":"10.1016\/j.msard.2020.102152_bib0011","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","article-title":"Fingolimod-associated macular edema: incidence, detection, and management","volume":"78","author":"Jain","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2020.102152_bib0012","doi-asserted-by":"crossref","first-page":"302","DOI":"10.3109\/09273948.2015.1125508","article-title":"Multiple sclerosis-related uveitis: does MS treatment affect uveitis course?","volume":"25","author":"Jouve","year":"2017","journal-title":"Ocul. Immunol. Inflamm."},{"issue":"12","key":"10.1016\/j.msard.2020.102152_bib0013","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.4049\/jimmunol.1700263","article-title":"New insights into the role of IL-1\u03b2 in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"198","author":"Lin","year":"2017","journal-title":"J. Immunol"},{"key":"10.1016\/j.msard.2020.102152_bib0014","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fimmu.2017.00200","article-title":"Cytokine signatures in mucocutaneous and ocular Beh\u00e7et's disease","volume":"8","author":"Lopalco","year":"2017","journal-title":"Front. Immunol"},{"issue":"6 Suppl 115","key":"10.1016\/j.msard.2020.102152_bib0015","first-page":"68","article-title":"Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy","volume":"36","author":"Lopalco","year":"2018","journal-title":"Clin. Exp. Rheumatol"},{"issue":"12","key":"10.1016\/j.msard.2020.102152_bib0016","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1001\/archneur.62.12.1843","article-title":"Efficacy of azathioprine on multiple sclerosis new brain lesions evaluated using magnetic resonance imaging","volume":"62","author":"Massacesi","year":"2005","journal-title":"Arch. Neurol"},{"issue":"6","key":"10.1016\/j.msard.2020.102152_bib0017","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/bjophthalmol-2015-306790","article-title":"Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis","volume":"100","author":"Miserocchi","year":"2016","journal-title":"The Brit. J. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102152_bib0018","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.survophthal.2016.07.002","article-title":"The association between multiple sclerosis and uveitis","volume":"62","author":"Olsen","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.msard.2020.102152_bib0020","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fimmu.2018.00925","article-title":"Selective modulation of TNF-TNFRs signaling: nsights insights for multiple sclerosis treatment","volume":"9","author":"Pegoretti","year":"2018","journal-title":"Front. Immunol"},{"issue":"5","key":"10.1016\/j.msard.2020.102152_bib0021","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1136\/annrheumdis-2011-200556","article-title":"Impact of IL-1 signalling on experimental uveitis and arthritis","volume":"71","author":"Planck","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.msard.2020.102152_bib0022","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/948154","article-title":"Untangling the web of systemic autoinflammatory diseases","volume":"2014","author":"Rigante","year":"2014","journal-title":"Mediators Inflamm"},{"issue":"1\u20132","key":"10.1016\/j.msard.2020.102152_bib0023","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0022-510X(01)00520-2","article-title":"Patients with multiple sclerosis and concomitant uveitis\/periphlebitis retinae are not distinct from those without intraocular inflammation","volume":"187","author":"Schmidt","year":"2001","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.msard.2020.102152_bib0024","first-page":"1","article-title":"Rituximab for sight-threatening refractory pediatric Vogt-Koyanagi-Harada disease","author":"Umran","year":"2015","journal-title":"Modern Rheumatol."},{"issue":"6","key":"10.1016\/j.msard.2020.102152_bib0025","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.oftal.2016.11.018","article-title":"Efficacy of immunomodulatory therapy with interferon-\u03b2 or glatiramer acetate on multiple sclerosis-associated uveitis","volume":"92","author":"Velazquez-Villoria","year":"2017","journal-title":"Arch. Soc. Esp. Oftalmol"},{"issue":"3-4","key":"10.1016\/j.msard.2020.102152_bib0026","first-page":"171","article-title":"Interleukin-1 Inhibition in Beh\u00e7et's disease","volume":"18","author":"Vitale","year":"2016","journal-title":"Isr. Med. Assoc. J"},{"issue":"2","key":"10.1016\/j.msard.2020.102152_bib0027","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1080\/09273940490895344","article-title":"Berta A and Foster CS. Multiple sclerosis-associated uveitis","volume":"12","author":"Zein","year":"2004","journal-title":"Ocul. Immunol. Inflamm."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820302285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:47:23Z","timestamp":1761900443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820302285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"alternative-id":["S2211034820302285"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102152","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety profile of anakinra in a HLA-B27 positive patient with multiple sclerosis-associated uveitis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102152","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102152"}}